Crown Castle Announces Proposed Public Offerings of Common

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
110
Crown Castle Announces Proposed Public Offerings of Common Stock and Mandatory Convertible Preferred Stock

HOUSTON, July 19, 2017 (GLOBE NEWSWIRE) -- Crown Castle International Corp. (NYSE: CCI ) ("Crown Castle") announced today that it is commencing concurrent offerings of $3.25 billion of shares of its common stock and $1.5 billion of shares of its Mandatory Convertible Preferred Stock, Series A, each in a separate registered public offering, subject to market and other conditions. These offerings are being made by means of separate prospectus supplements and are not contingent on each other or upon the consummation of the recently announced transaction between LTS Group Holdings LLC (“Lightower”) and Crown Castle (“Lightower Transaction”). Crown Castle expects to use the net proceeds from these offerings, together with the net proceeds from additional debt financing, which may include additional borrowings under its revolving credit facility, to finance the consideration to be paid in connection with the Lightower Transaction. If for any reason the Lightower Transaction does not close or closes for reduced consideration, then Crown Castle expects to use the net proceeds from these offerings for general corporate purposes, which may include, in the Company’s sole discretion, the redemption of the Mandatory Convertible Preferred Stock and the repurchase or repayment of indebtedness. Crown Castle intends to grant the underwriters in each respective offering the option to purchase up to an additional $325 million of shares of its common stock and up to an additional $150 million of shares of its Mandatory Convertible Preferred Stock.

Morgan Stanley, BofA Merrill Lynch and J.P. Morgan are acting as joint bookrunners of the offerings and representatives of the underwriters. Additionally, Barclays and RBC Capital Markets are acting as joint bookrunners of the offerings.

The offerings are being made pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission (“SEC”). Each offering will be made only by means of a prospectus supplement relating to such offering and the accompanying base prospectus, copies of which may be obtained by contacting the underwriters using the information provided below. An electronic copy of the preliminary prospectus supplement, together with the accompanying prospectus, is also available on the SEC’s website, www.sec.gov .

This press release shall not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Cautionary Language Regarding Forward-Looking Statements   This press release contains forward-looking statements that are based on Crown Castle management’s current expectations.  Such statements include plans, projections and estimates regarding the use of proceeds from the proposed offerings.  Such forward-looking statements are subject to certain risks, uncertainties and assumptions, including prevailing market conditions and other factors.  Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those expected.  More information about potential risk factors that could affect Crown Castle and its results is included in Crown Castle’s filings with the SEC.  The term “including,” and any variation thereof, means “including, without limitation.”

UNDERWRITER CONTACT INFORMATION

Morgan Stanley & Co. LLC 180 Varick St, 2 nd Floor, New York, New York 10014 Attn: Prospectus Department Toll-free: (866) 718-1649 BofA Merrill Lynch 200 North College Street, 3 rd Floor Charlotte, NC 28255-0001 Attn: Prospectus Department Dg.prospectus_requests@baml.com
   
J.P. Morgan Securities LLC c/o Broadridge Financial Solutions 1155 Long Island Avenue, Edgewood, NY 11717 Attn: Prospectus Department Toll-free: 1-866-803-9204  
   

Contacts: Dan Schlanger, CFO Son Nguyen, VP & Treasurer Crown Castle International Corp. 713-570-3050

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Smart Living Solutions Unveiled by Hisense at CES 2026

Updated Category News Views 136

Hisense Unveils Smart Living Innovations at CES 2026 Hisense has made headlines once again at CES 2026 by presenting an impressive array of smart living solutions that integrate seamlessly into everyday life. The company, recognized worldwide for its prowess in consumer electronics and home appliances, demonstrated its commitment to enhancing modern living through...

Continue Reading
Exploring the Innovations of Oncotelic Therapeutics Inc.

Updated Category News Views 103

Oncotelic Therapeutics: A Leader in Cancer Innovations Oncotelic Therapeutics Inc. (NASDAQ: OTLC), a pioneering clinical-stage biopharmaceutical company, is committed to advancing groundbreaking therapies in oncology and immunotherapy. The organization specializes in developing innovative treatments for difficult-to-treat cancers and rare diseases. This vision is...

Continue Reading
Introducing EMBREY Insights: A New Perspective on Investments

Updated Category News Views 128

Introducing EMBREY Insights: A New Publication for Investors New Publication Focuses on the Emerging Strength of Multifamily Investments EMBREY, a vertically integrated real estate investment company, recently announced the launch of its latest research periodical, EMBREY Insights. This new publication aims to deliver expert research and insights on multifamily investment...

Continue Reading
Oportun's Strategic Alliance with Findell Capital Management

Updated Category News Views 105

Oportun Enters Strategic Cooperation Agreement Oportun Financial Corporation (Nasdaq: OPRT), a dedicated financial services firm, has embarked on a groundbreaking journey by entering a multi-year cooperation agreement with Findell Capital Management LLC. This collaborative move marks a significant milestone in maintaining harmonious relations within the company’s...

Continue Reading
Nutricosmetics Market Expected to Surpass $15 Billion by 2033

Updated Category News Views 174

Nutricosmetics Market Overview The global nutricosmetics market is on a trajectory for substantial growth, with projections estimating a rise from USD 8.28 billion in the near future to USD 15.36 billion by 2033. According to industry insights, this growth represents a compound annual growth rate (CAGR) of 8.07% from 2026 to 2033. The increasing awareness regarding the...

Continue Reading